94 related articles for article (PubMed ID: 16778749)
1. [Perfusion MR imaging in brain tumors].
Le Bas JF; Grand S; Krainik A; Lefournier V; Tropres I; Rémy C
J Radiol; 2006 Jun; 87(6 Pt 2):807-21. PubMed ID: 16778749
[TBL] [Abstract][Full Text] [Related]
2. Dynamic magnetic resonance perfusion imaging of brain tumors.
Covarrubias DJ; Rosen BR; Lev MH
Oncologist; 2004; 9(5):528-37. PubMed ID: 15477637
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance perfusion and permeability imaging in brain tumors.
Lacerda S; Law M
Neuroimaging Clin N Am; 2009 Nov; 19(4):527-57. PubMed ID: 19959004
[TBL] [Abstract][Full Text] [Related]
4. Advanced neuroimaging of pediatric brain tumors: MR diffusion, MR perfusion, and MR spectroscopy.
Poussaint TY; Rodriguez D
Neuroimaging Clin N Am; 2006 Feb; 16(1):169-92, ix. PubMed ID: 16543091
[TBL] [Abstract][Full Text] [Related]
5. Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in pediatric patients.
Cha S
Neuroimaging Clin N Am; 2006 Feb; 16(1):137-47, ix. PubMed ID: 16543089
[TBL] [Abstract][Full Text] [Related]
6. Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients.
Bendini M; Marton E; Feletti A; Rossi S; Curtolo S; Inches I; Ronzon M; Longatti P; Di Paola F
Acta Neurochir (Wien); 2011 Feb; 153(2):403-12. PubMed ID: 21165751
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Parotid Tumors With Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted MR Imaging.
Abdel Razek AA; Samir S; Ashmalla GA
J Comput Assist Tomogr; 2017 Jan; 41(1):131-136. PubMed ID: 27636248
[TBL] [Abstract][Full Text] [Related]
8. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MR Imaging in the Assessment of Brain Tumors.
Kimura M; da Cruz LCH
Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):87-122. PubMed ID: 26613877
[TBL] [Abstract][Full Text] [Related]
10. Contrast-Enhanced Perfusion MR Imaging to Differentiate Between Recurrent/Residual Brain Neoplasms and Radiation Necrosis.
Metaweh NAK; Azab AO; El Basmy AAH; Mashhour KN; El Mahdy WM
Asian Pac J Cancer Prev; 2018 Apr; 19(4):941-948. PubMed ID: 29693348
[TBL] [Abstract][Full Text] [Related]
11. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy.
She DJ; Xing Z; Zeng Z; Shang XY; Cao DR
Neuroradiology; 2015 Mar; 57(3):275-81. PubMed ID: 25487356
[TBL] [Abstract][Full Text] [Related]
13. Perfusion MR imaging of enhancing brain tumors: Comparison of arterial spin labeling technique with dynamic susceptibility contrast technique.
Soni N; Dhanota DPS; Kumar S; Jaiswal AK; Srivastava AK
Neurol India; 2017; 65(5):1046-1052. PubMed ID: 28879895
[TBL] [Abstract][Full Text] [Related]
14. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors.
Siegal T; Rubinstein R; Tzuk-Shina T; Gomori JM
J Neurosurg; 1997 Jan; 86(1):22-7. PubMed ID: 8988077
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.
Sunwoo L; Choi SH; Yoo RE; Kang KM; Yun TJ; Kim TM; Lee SH; Park CK; Kim JH; Park SW; Sohn CH; Won JK; Park SH; Kim IH
Neuroradiology; 2015 Nov; 57(11):1111-20. PubMed ID: 26232204
[TBL] [Abstract][Full Text] [Related]
16. Perfusion MR imaging and MR spectroscopy of gemistocytic astrocytoma.
Godefroy A; Derrey S; Laquerrière A; Perot G; Proust F; Gerardin E
J Neuroradiol; 2012 Jul; 39(3):190-4. PubMed ID: 22115534
[TBL] [Abstract][Full Text] [Related]
17. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging.
Preul C; Kühn B; Lang EW; Mehdorn HM; Heller M; Link J
Eur J Radiol; 2003 Dec; 48(3):244-51. PubMed ID: 14652141
[TBL] [Abstract][Full Text] [Related]
19. Perfusion and permeability MR imaging of gliomas.
Shiroishi MS; Habibi M; Rajderkar D; Yurko C; Go JL; Lerner A; Mogensen MA; Kim PE; Boyko OB; Zee CS; Law M
Technol Cancer Res Treat; 2011 Feb; 10(1):59-71. PubMed ID: 21214289
[TBL] [Abstract][Full Text] [Related]
20. Diffusion and perfusion magnetic resonance imaging in brain tumors.
Le Bihan D; Douek P; Argyropoulou M; Turner R; Patronas N; Fulham M
Top Magn Reson Imaging; 1993; 5(1):25-31. PubMed ID: 8416686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
